Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02764476 · ClinicalTrials.gov registry record · NA

Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder

A NA study, sponsored by Stanford University.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT02764476: Clinical Trial NA study, sponsored by Stanford University.

NCT02764476 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02764476, a NA study, was terminated before completion, sponsored by Stanford University.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The purpose of this study is to design and test the safety and feasibility of virtual reality technologies and experiences of egocentric avatar embodiment in the application of physical and cognitive behavior therapy in functional neurological symptom/conversion disorder. Investigators hypothesize that patients will safely use and accept this modality of treatment and will show evidence of a decrease in symptom frequency.

Primary Outcome

Number of sessions attended over 12 weeks recorded by therapist

Interventions

  • OTHER Virtual reality
  • OTHER Embodied Virtual Reality Therapy

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2016-05
Est. Completion 2021-12
Phase NA
Stanford University

1,744 total trials

Why NCT02764476 stopped before completion

NCT02764476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Virtual reality is the first listed.

NCT02764476 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02764476 about?

NCT02764476 is a clinical study titled "Embodied Virtual Reality Therapy for Functional Neurological Symptom/ Conversion Disorder". The purpose of this study is to design and test the safety and feasibility of virtual reality technologies and experiences of egocentric avatar embodiment in the application of physical and cognitive behavior therapy in functional neurological symptom/conversion disorder. Investigators hypothesize t...

What is the current status of trial NCT02764476?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2016-05. Estimated completion is 2021-12.

What interventions are being tested in trial NCT02764476?

The interventions under investigation include: Virtual reality (OTHER), Embodied Virtual Reality Therapy (OTHER).

Who is sponsoring clinical trial NCT02764476?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02764476's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02764476, the US trial registry maintained by the National Library of Medicine. NCT02764476 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.